Physician profile
Michael P Pizzuto
NPI 1801892286
$1,165.01
in general payments reported to CMS, 2019-2025
8 companies · $62.55 in 2025
The $62.55 reported for 2025 was less than what a typical Pediatric Otolaryngology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $130 · 2021: $156 · 2022: $265 · 2023: $126 · 2024: $213 · 2025: $62.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $368.89 | 2022-2024 | Coblation, Tula, Halo |
| Cochlear Americas | $219.56 | 2021-2022 | |
| Integra Lifesciences Corporation | $140.39 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Alk-Abello, INC | $129.88 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $105.35 | 2019 | |
| Stryker Corporation | $95.18 | 2019-2025 | Xpress Loprofile |
| Acclarent, INC | $94.50 | 2019-2021 | |
| Karl Storz Endoscopy-America | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pizzuto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.